Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07351981
NA

TcPRF for Knee Osteoarthritis

Sponsor: National and Kapodistrian University of Athens

View on ClinicalTrials.gov

Summary

Objectives * Primary Objective: To evaluate the efficacy of transcutaneous PRF treatment in reducing knee pain compared to a sham intervention * Secondary Objectives: To assess the improvement in functional outcomes and patient satisfaction following PRF treatment. Study Design * Type: Randomized, double-blind, sham-controlled study. * Duration: 6 months * Study Population: Adults aged 40-75 years with chronic knee pain (lasting ≥ 6 months) due to osteoarthritis (OA). * How many patients in each group: 25 patients in each group (according to Janssens et al, 2024) Inclusion Criteria * Diagnosed with knee osteoarthritis according to NICE criteria. * Chronic knee pain (Visual Analogue Scale \[VAS\] ≥ 4). * Failure to respond adequately to conventional treatments (e.g., NSAIDs, physical therapy). * Willingness to comply with study procedures. Exclusion Criteria * Previous PRF/RF treatment for knee pain. * Hyaluronic acid injection for knee pain in the past 6 months * Knee surgery within the last 6 months. * Severe cardiovascular, neurological, or psychiatric conditions. * Active systemic infections or local skin infections at the knee. * Pregnancy or lactation.

Official title: Randomized Double-Blind Study to Evaluate the Efficacy of Transcutaneous Pulsed Radiofrequency (PRF) Treatment for Knee Pain

Key Details

Gender

All

Age Range

45 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2026-01-15

Completion Date

2026-06-01

Last Updated

2026-01-20

Healthy Volunteers

No

Interventions

DEVICE

Transcutaneous Pulsed Radiofrequency (PRF) Treatment for Knee Pain

application of TcPRF patches

DEVICE

sham treatment of pulsed rf on knee

Transdermal patch will be connected to demo mode of the spring pulsed rf generator. no treatment will be given

Locations (1)

Aretaieion University Hospital

Athens, Greece